MediciNova, Inc. announced the appointment of David H. Crean, Ph.D., as Chief Business Officer. Dr. Crean is President and CEO of Coast BioVentures LLC. Previously, Dr. Crean served as Managing Director for Objective Capital Partners, LLC (“Objective”) driving Objective’s practice in the same practice domains, and currently serves in a senior advisory capacity with his former firm. Dr. Crean currently serves in leading roles on the Boards of Directors for Histogen, Inc. as Board Chairman and the former Chairman of the Audit Committee, and the California Life Sciences Association (“CLSA”) as a member of the Executive Committee.